Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MATTHEW C SOPHY

Allopathic & Osteopathic Physicians Family Medicine Adult Medicine

NPI
1922071620
CMS profile
314472
Location
PORT CARBON, PA

General Payments · PY2018–2024

$2,390.48

  • Reported across 140 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$287.41

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $287.41 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $101.43 5
Amgen Inc. $79.98 4
Novo Nordisk AS $68.99 4
Sumitomo Pharma America, Inc. $22.76 1
ABBVIE INC. $14.25 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $468.82 31
PY2019 $601.04 34
PY2020 $169.17 10
PY2021 $259.18 16
PY2022 $239.27 14
PY2023 $365.59 20
PY2024 $287.41 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.25 03/26/2024 Food and Beverage Undisputed 01/23/2026 1106140444 CMS
Amgen Inc. $19.63 03/13/2024 Food and Beverage Undisputed 01/23/2026 1116143666 CMS
Amgen Inc. $20.57 07/10/2024 Food and Beverage Undisputed 01/23/2026 1117388280 CMS
Amgen Inc. $16.46 10/15/2024 Food and Beverage Undisputed 01/23/2026 1117388282 CMS
Amgen Inc. $23.32 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116143658 CMS
Lilly USA, LLC $21.39 01/03/2024 Food and Beverage Undisputed 01/23/2026 1135184339 CMS
Lilly USA, LLC $25.97 01/30/2024 Food and Beverage Undisputed 01/23/2026 1135183093 CMS
Lilly USA, LLC $18.78 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135206214 CMS
Lilly USA, LLC $17.20 04/10/2024 Food and Beverage Undisputed 01/23/2026 1135193586 CMS
Lilly USA, LLC $18.09 05/15/2024 Food and Beverage Undisputed 01/23/2026 1135170316 CMS
Novo Nordisk Inc $16.61 01/23/2024 Food and Beverage Undisputed 01/23/2026 1097508527 CMS
Novo Nordisk Inc $22.17 04/08/2024 Food and Beverage Undisputed 01/23/2026 1096870707 CMS
Novo Nordisk Inc $16.21 08/07/2024 Food and Beverage Undisputed 01/23/2026 1096617726 CMS
Novo Nordisk Inc $14.00 12/18/2024 Food and Beverage Undisputed 01/23/2026 1097174637 CMS
Sumitomo Pharma America, Inc. $22.76 07/09/2024 Food and Beverage Undisputed 01/23/2026 1148922369 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.